weight loss expectations with tirzepatide weight-loss study shows promising results How Much Weight Will I
Description
A 2025 study found that stopping GLP-1 medications before pregnancy is associated with significant weight regain during pregnancy, plus higher risks of gestational diabetes, preterm delivery, and high blood pressure

Although both act on the GLP-1 pathway to stimulate insulin release, slow stomach emptying, and reduce appetite, they were developed with different target populations in mind

3-5g daily

doi: 10.1016/j.amjcard.2024.04.041 32 TanHCDampilOAMarquezMM

Some of the alleged injuries include gastrointestinal conditions, pancreatic diseases, gallbladder issues, and blood clots
